Search for: "WARNER-LAMBERT CO V US"
Results 61 - 80
of 124
Sort by Relevance
|
Sort by Date
28 Nov 2011, 3:30 am
Warner–Lambert Co., 265 F.3d 853 (9th Cir.2001) the Ninth Circuit held that attorney’s fees must be divided among all members of the plaintiff class for purposes of amount in controversy. [read post]
15 Sep 2011, 5:00 am
Warner-Lambert Co., 799 F. [read post]
14 Aug 2011, 11:13 am
To establish a false advertising claim, Pernod must prove the following under Warner-Lambert v Breathasure (2000), that:Bacardi made false or misleading statements as to his own product [or another's];there is actual deception or at least a tendency to deceive a substantial portion of the intended audience;the deception is material in that it is likely to influence purchasing decisions;the advertised goods travel in interstate commerce; andthere is a likelihood of… [read post]
7 Jul 2011, 2:31 pm
Warner–Lambert & Co., 467 F.3d 85 (2d Cir. 2007), presumed to know more about Michigan law than either the Michigan courts (Taylor v. [read post]
29 Jun 2011, 3:34 am
(Patent Docs) Lipitor (Atorvastatin) – UK Atorvastatin hearing for 11 July – Warner-Lambert v Teva UK (The SPC Blog) Metoclopramide – US: Supreme Court issues decision on generic drug pre-emption: To borrow from Harry Caray – “Holy cow! [read post]
11 May 2011, 10:14 pm
Warner Bros. [read post]
4 May 2011, 4:13 am
(Patent Law Practice Center) US: Abraxis files for patent term adjustment calculation review for patent entitled ‘Compositions and methods of delivery of pharmacological agents’ (Patent Docs) US: ITC: Target date set in Certain Vaginal Ring Birth Control Devices (ITC 337 Law Blog) US: Court confused by patent reexamination results: Cellectricon v Fluxion Biosciences (Patents Post-Grant) Products AndroGel (Testosterone) – US: Abbott sues… [read post]
4 Nov 2010, 1:38 pm
" In 2004, Warner-Lambert (owned by Pfizer) pled guilty to two felony counts of marketing Neurontin for various unapproved uses and paid a $240 million criminal fine and a $190 million civil fine. [read post]
2 Nov 2010, 1:40 am
AstraZeneca v. [read post]
6 Sep 2010, 10:21 am
Warner-Lambert & Co., 467 F.3d 85 (2d Cir. 2006), aff'd by equally divided court, 552 U.S. 440 (2008). [read post]
21 Jul 2010, 3:10 pm
Most notoriously, the Supreme Court fought this issue to a 4-4 draw back in 2008 (in Warner-Lambert v. [read post]
14 Jan 2010, 11:09 am
” Warner-Lambert Co. v. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/23: Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company, LLC v. [read post]
8 Oct 2009, 4:24 am
Warner-Lambert Co. at 8-9, No. 04-10150 (D. [read post]
1 Oct 2009, 6:04 am
Warner-Lambert Co., 326 F.3d 339 (2d Cir. 2003) -- because it involved an underlying misrepresentation to TPPs about the safety of a drug. [read post]
19 Sep 2009, 9:54 am
Pfizer's Warner-Lambert unit paid $430 million in 2004 to resolve off-label marketing allegations involving Neurontin by the U.S. [read post]
17 Sep 2009, 4:30 am
See Johnson v. [read post]
2 Sep 2009, 11:22 pm
Warner-Lambert & Co., 467 F.3d 85 (2d Cir. 2006), aff'd by equally divided court, 128 S. [read post]
31 Aug 2009, 12:14 pm
The Court relied on the test in Warner-Lambert Co v. [read post]
10 Aug 2009, 10:00 pm
Warner-Lambert v. [read post]
